Innovative statistical method helps determine ideal threshold times in restricted mean survival time analyses.

As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA platforms will only grow in significance. For rare disease trials, where patient ...

Encouraged by initial successes with ketamine, researchers including Peter Nagele, a professor of anesthesia and psychiatry ...

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

Executing more clinical ... research funding to Africa went to just three countries (ie, South Africa, Kenya, and Uganda) according to 2024 data on the World RePORT database. However, the number of ...

From laboratory bench to bedside, researchers in the Clinical Research Division develop and analyze new treatments for cancers and other diseases. Through these studies, our scientists discover new ...

A person with a greater chance of developing a specific condition who meets certain criteria may qualify to participate in a clinical research study for diagnosis or treatment. While Medicare does ...

The traditional diet of restricting calories is a tried-and-true method for weight loss — but new research reveals that ... After the year-long study, the intermittent fasters reported an ...